Mereo Biopharma Group PLC
NASDAQ:MREO
Mereo Biopharma Group PLC
NASDAQ:MREO
Price:
3.01 USD
-2.9%
Market Closed
Updated:
May 8, 2024
Cash Flow Statement
Cash Flow Statement
Mereo Biopharma Group PLC
Mereo Biopharma Group PLC
Currency: GBP
| Dec-2020 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | ||
|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||
| Net Income |
(166)
|
14
|
(6)
|
(36)
|
(28)
|
|
| Depreciation & Amortization |
2
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
2
|
3
|
0
|
4
|
0
|
|
| Other Non-Cash Items |
129
|
(21)
|
(21)
|
(4)
|
0
|
|
| Cash Taxes Paid |
(10)
|
(3)
|
(1)
|
2
|
0
|
|
| Cash Interest Paid |
3
|
0
|
0
|
0
|
1
|
|
| Change in Working Capital |
7
|
1
|
1
|
0
|
(6)
|
|
| Cash from Operating Activities |
(28)
N/A
|
(5)
+82%
|
(24)
-359%
|
(39)
-61%
|
(33)
+14%
|
|
| Investing Cash Flow | ||||||
| Capital Expenditures |
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Other Items |
2
|
0
|
1
|
2
|
1
|
|
| Cash from Investing Activities |
2
N/A
|
(0)
N/A
|
1
N/A
|
2
+171%
|
1
-56%
|
|
| Financing Cash Flow | ||||||
| Net Issuance of Common Stock |
20
|
79
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
22
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other |
(8)
|
(0)
|
(0)
|
0
|
(1)
|
|
| Cash from Financing Activities |
35
N/A
|
78
+124%
|
77
0%
|
(1)
N/A
|
(1)
-81%
|
|
| Change in Cash | ||||||
| Effect of Foreign Exchange Rates |
(1)
|
(1)
|
(1)
|
0
|
(0)
|
|
| Net Change in Cash |
7
N/A
|
71
+893%
|
53
-25%
|
(38)
N/A
|
(34)
+10%
|
|
| Free Cash Flow | ||||||
| Free Cash Flow |
(28)
N/A
|
(6)
+80%
|
(25)
-325%
|
(39)
-58%
|
(34)
+13%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
